U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
SOLANEZUMAB
5D6PWO0333
Investigational
General
Names
10
Classification
1
Identifiers
9
Subunits
4
Related Substances
1
SOLANEZUMAB
5D6PWO0333
Investigational
General
Approval Year
Unknown
149,124
Names
10
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
SOLANEZUMAB
Official Name
English
LY-2062430
Preferred Name
English
solanezumab [INN]
Common Name
English
IMMUNOGLOBULIN G1, ANTI-(HUMAN .BETA.-AMYLOID) (HUMAN-MOUSE MONOCLONAL LY2062430 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL LY2062430 LIGHT CHAIN, DIMER
Common Name
English
LY2062430
Code
English
Showing 1 to 5 of 10 entries
Previous
1
2
Next
Classification
1
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
NCI_THESAURUS
C20401
Showing 1 to 1 of 1 entries
Previous
1
Next
Identifiers
9
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
EVMPD
SUB37126
PRIMARY
ChEMBL
CHEMBL1743072
PRIMARY
DRUG BANK
DB11756
PRIMARY
CAS
955085-14-0
PRIMARY
FDA UNII
5D6PWO0333
PRIMARY
Showing 1 to 5 of 9 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
5D6PWO0333
SOLANEZUMAB